Skip to content
1st Counsel – Lifestyle
Author:
Ping An Biomedical Co., Ltd
Ping An Biomedical Announces Planned Acquisition of Three Tumor Cell-Related Medical Technology Patents to Build a Core Oncology and Biotech Intellectual Property Portfolio
October 22, 2026
Ping An Biomedical Announces 1-for-40 Reverse Stock Split
October 21, 2026
Ping An Biomedical and Yuan Sheng Mei Yan Sign Strategic Cooperation Agreement, Targeting RMB 500 Million in Sales Over Three Years
July 22, 2026